FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2007314270> ?p ?o ?g. }

• W2007314270 endingPage "66" @default.
• W2007314270 startingPage "57" @default.
• W2007314270 abstract "Proteasome inhibition represents a promising novel anticancer therapy, and bortezomib is a highly selective reversible inhibitor of the proteasome complex. Acute myeloid leukemia (AML) is an immnunophenotypically heterogeneous group of diseases, with CD34(+) cases being associated with drug resistance and poor outcome. We investigated the effects of bortezomib on the growth and survival of AML cells.We studied the in vitro activity and mechanism of action of bortezomib on both cell lines and fresh cells from 28 AML patients including CD34(+) and CD34(-) cases.Bortezomib showed potent anti-AML activity (IC(50) < 50 nM), which was greater than that of conventional agents (doxorubicin, cytarabine and fludarabine). Moreover, synergistic effects were observed when bortezomib was administered in combination with doxorubicin and cytarabine. Mechanistically, bortezomib induced accumulation of cells in the G(2)/M phase, with up-regulation of p27, together with cell death through an increase in the mitochondrial outer membrane permeability involving caspase-dependent and -independent pathways. The apoptotic activity of bortezomib on fresh CD34(+) blast cells from patients was similar to that observed on CD34(-)blast cells. Importantly, bortezomib was significantly more active than doxorubicin in the immature CD34(+) cells, while there were no differences in its action on CD34(-) cells.Bortezomib induces apoptosis in acute myeloid leukemia cells in vitro. Whether this drug might be useful in the treatment of patients with acute myeloid leukemia can be established only in ad hoc clinical trials." @default.
• W2007314270 created "2016-06-24" @default.
• W2007314270 creator A5018071694 @default.
• W2007314270 creator A5020989412 @default.
• W2007314270 creator A5032870970 @default.
• W2007314270 creator A5037517555 @default.
• W2007314270 creator A5051903959 @default.
• W2007314270 creator A5054921200 @default.
• W2007314270 creator A5059323129 @default.
• W2007314270 creator A5069753479 @default.
• W2007314270 creator A5077742070 @default.
• W2007314270 creator A5078363282 @default.
• W2007314270 date "2008-01-01" @default.
• W2007314270 modified "2023-10-14" @default.
• W2007314270 title "The effect of the proteasome inhibitor bortezomib on acute myeloid leukemia cells and drug resistance associated with the CD34+ immature phenotype" @default.
• W2007314270 cites W1607777232 @default.
• W2007314270 cites W1630927736 @default.
• W2007314270 cites W1654790906 @default.
• W2007314270 cites W1938721925 @default.
• W2007314270 cites W1964420304 @default.
• W2007314270 cites W1988356885 @default.
• W2007314270 cites W1988743502 @default.
• W2007314270 cites W1989150871 @default.
• W2007314270 cites W1994631062 @default.
• W2007314270 cites W1998922870 @default.
• W2007314270 cites W2018690104 @default.
• W2007314270 cites W2021808416 @default.
• W2007314270 cites W2023424949 @default.
• W2007314270 cites W2028521588 @default.
• W2007314270 cites W2032481064 @default.
• W2007314270 cites W2038736055 @default.
• W2007314270 cites W2039839254 @default.
• W2007314270 cites W2043432881 @default.
• W2007314270 cites W2044942890 @default.
• W2007314270 cites W2060597905 @default.
• W2007314270 cites W2074725580 @default.
• W2007314270 cites W2077945404 @default.
• W2007314270 cites W2079100773 @default.
• W2007314270 cites W2080199075 @default.
• W2007314270 cites W2081510209 @default.
• W2007314270 cites W2083308557 @default.
• W2007314270 cites W2090379314 @default.
• W2007314270 cites W2099198727 @default.
• W2007314270 cites W2099878195 @default.
• W2007314270 cites W2108235071 @default.
• W2007314270 cites W2110385671 @default.
• W2007314270 cites W2111810335 @default.
• W2007314270 cites W2112144631 @default.
• W2007314270 cites W2114918609 @default.
• W2007314270 cites W2115219209 @default.
• W2007314270 cites W2118886727 @default.
• W2007314270 cites W2120204058 @default.
• W2007314270 cites W2121001769 @default.
• W2007314270 cites W2122684890 @default.
• W2007314270 cites W2124560610 @default.
• W2007314270 cites W2127971712 @default.
• W2007314270 cites W2134657928 @default.
• W2007314270 cites W2138102966 @default.
• W2007314270 cites W2146191388 @default.
• W2007314270 cites W2146502962 @default.
• W2007314270 cites W2148537814 @default.
• W2007314270 cites W2152065071 @default.
• W2007314270 cites W2152643523 @default.
• W2007314270 cites W2153916767 @default.
• W2007314270 cites W2155468968 @default.
• W2007314270 cites W2156748957 @default.
• W2007314270 cites W2160380481 @default.
• W2007314270 cites W2160972799 @default.
• W2007314270 cites W2163679078 @default.
• W2007314270 cites W2166043738 @default.
• W2007314270 cites W2170846829 @default.
• W2007314270 cites W2182311866 @default.
• W2007314270 cites W2186263933 @default.
• W2007314270 cites W2275671604 @default.
• W2007314270 cites W2571142173 @default.
• W2007314270 doi "https://doi.org/10.3324/haematol.11666" @default.
• W2007314270 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/18166786" @default.
• W2007314270 hasPublicationYear "2008" @default.
• W2007314270 type Work @default.
• W2007314270 sameAs 2007314270 @default.
• W2007314270 citedByCount "58" @default.
• W2007314270 countsByYear W20073142702012 @default.
• W2007314270 countsByYear W20073142702013 @default.
• W2007314270 countsByYear W20073142702014 @default.
• W2007314270 countsByYear W20073142702015 @default.
• W2007314270 countsByYear W20073142702016 @default.
• W2007314270 countsByYear W20073142702017 @default.
• W2007314270 countsByYear W20073142702019 @default.
• W2007314270 countsByYear W20073142702020 @default.
• W2007314270 countsByYear W20073142702021 @default.
• W2007314270 countsByYear W20073142702022 @default.
• W2007314270 countsByYear W20073142702023 @default.
• W2007314270 crossrefType "journal-article" @default.
• W2007314270 hasAuthorship W2007314270A5018071694 @default.
• W2007314270 hasAuthorship W2007314270A5020989412 @default.
• W2007314270 hasAuthorship W2007314270A5032870970 @default.
• W2007314270 hasAuthorship W2007314270A5037517555 @default.
• W2007314270 hasAuthorship W2007314270A5051903959 @default.

• next